Watch GlaxoSmithKline explain  

why they have invested in Denmark

2012.01.10
 

Mike Connell, V.P. and General Manager of GlaxoSmithKline Denmark, explains why one of the world's leading research-based pharmaceutical companies has chosen to invest in Denmark.

Please install the flash plugin

Next step

Explore business cases

Contact

Tine Hartmann Nielsen

Tine Hartmann Nielsen

+45 3392 1350

tiniel@um.dk

Please contact me

Name
Company
E-mail
Phone
How can we help you?

Areas of

business excellence

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×